Yajun He

Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases

Jiqian Xu, Deyi Sun, Y. Shang, 2022, Frontiers in Immunology.

FBXL2 counteracts Grp94 to destabilize EGFR and inhibit EGFR-driven NSCLC growth

Yuhuang Li, Zhonghan Li, Jian Yang, 2021, Nature Communications.

Noncanonical TGF-β signaling leads to FBXO3-mediated degradation of ΔNp63α promoting breast cancer metastasis and poor clinical prognosis

Tao He, Z. Xiao, Y. Yi, 2021, PLoS biology.